National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2019 (No. 12) (PB 105 of 2019) (Cth)

PB 105 of 2019

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2019 (No. 12)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated         20^th December 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2019 (No. 12).

(2)This Instrument may also be cited as PB 105 of 2019.

1. Commencement

This Instrument commences on 1 January 2020.

1. Amendment of National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, after entry for Abatacept in the form Injection 125 mg in 1 mL single dose pre-filled syringe

insert:

Abemaciclib	Tablet 50 mg	20	56	5
Tablet 100 mg	20	56	5
Tablet 150 mg	20	56	5

1. Schedule 1, after entry for Primidone in the form Tablet 250 mg

insert:

Tablet 250 mg (USP) 20 200 2